Cargando…
A current evaluation of the safety of angiotensin receptor blockers and direct renin inhibitors
The safety of angiotensin II receptor blockers (ARBs) for the treatment of hypertension and cardiovascular and renal diseases has been well documented in numerous randomized clinical trials involving thousands of patients. However, recent concerns have surfaced about possible links between ARBs and...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Dove Medical Press
2011
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104607/ https://www.ncbi.nlm.nih.gov/pubmed/21633727 http://dx.doi.org/10.2147/VHRM.S15541 |